← Back to Search

PERCCS: Personalized Education Regarding Clinical and Community Supports for Longitudinal Cohort Study (SURROuND Trial)

N/A

Waitlist Available

Led By John N Constantino, MD

Research Sponsored by Washington University School of Medicine

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up not more than 18 months postpartum

Awards & highlights

SURROuND Trial Summary

This trial is a randomized controlled trial embedded within a prospective longitudinal study, in which families of infants recruited prenatally or in the newborn period are randomized to an enhanced level of engagement in resource navigation, which we refer to as Personalized Education Regarding Clinical and Community Supports (PERCCS). The enhancement involves keying recommendations for evidence-informed interventions for the prevention of CM to established risk factors for ascertained within a family.

Who is the study for?

This trial is for Missouri residents who are at least 18 years old and using BJC Healthcare Obstetrics or Newborn Services. It's not open to those under 18, non-residents, or people not engaged with these specific healthcare services.Check my eligibility

What is being tested?

The study tests an enhanced support program called PERCCS (Personalized Education Regarding Clinical and Community Supports) aimed at preventing child maltreatment by providing families with targeted interventions based on risk factors identified at birth.See study design

What are the potential side effects?

Since this trial involves educational and community support interventions rather than medical treatments, traditional physical side effects are not applicable. However, there may be emotional or psychological impacts from participating in the program.

SURROuND Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ not more than 18 months postpartum

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~not more than 18 months postpartum

This trial's timeline: 3 weeks for screening, Varies for treatment, and not more than 18 months postpartum for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Child Maltreatment

Service Utilization

SURROuND Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: High RiskExperimental Treatment1 Intervention

High risk families in prospective longitudinal study of newborns (n=150*). *Participants will be randomized 2:1 PERCCS:Control, and the randomization will be within successive sets of three families who fall in either "high risk" counts (n=105) families for child maltreatment or "low risk" counts (n=45) families. Participants in this arm will be randomized to: PERCCS (see attached figure and table for details) Care as Usual

Group II: Low RiskActive Control1 Intervention

Low risk natural history study (n=250*) *Participants will be randomized 2:1 PERCCS:Control, and the randomization will be within successive sets of three families who fall in either "high risk" counts (n=105) families for child maltreatment or "low risk" counts (n=45) families.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Washington University School of MedicineLead Sponsor

1,931 Previous Clinical Trials

2,299,604 Total Patients Enrolled

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH

1,963 Previous Clinical Trials

2,674,636 Total Patients Enrolled

John N Constantino, MDPrincipal InvestigatorFaculty

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals currently able to participate in this experiment?

"Accurate. Per clinicaltrials.gov records, this trial is actively enrolling participants with the platform first being posted on January 26th 2021 and last updated on July 19th 2022."

Answered by AI

How many participants is the research team recruiting for this clinical trial?

"Affirmative. Clinicaltrials.gov's records indicate that this research venture, which was first made public on January 26th 2021, is actively recruiting participants. 150 volunteers need to be recruited from one medical centre."

Answered by AI

What criteria must I fulfill in order to participate in this experiment?

"The eligibility criteria mandates that potential participants possess the karyopherin alpha 2 gene and are between 18-99 years of age. The total number of patients to be included in the trial is 150."

Answered by AI